Effect of JAK inhibitors on extraintestinal manifestations and concurrent immune-mediated inflammatory diseases in patients with inflammatory bowel disease.

Truyens M, Tolstoy X, Calabrese G, Cremer A, Lewandowski K, Argyriou K, Drygiannakis I, Shakweh E, Pastras P, Kani HT, García MJ, Gordon H, Ribaldone DG, Karmiris K, Felice C, Yudego IM, Blesl A, Todeschini A, Balestrieri P, Filip R, Taelman T, Vladimirova N, Michalopoulos G, Attauabi M, Pouillon L, Noor N, Innocenti T, Vieujean S, Karakan T, Barreiro-de Acosta M, Mocci G, Estevinho MM, Savarino EV, Jauregui-Amezaga A, Holvoet T, Kapizioni C, Dagci G, Vrakas S, Hedin CRH, Nardone OM, Rydzewska G, Koutroubakis I, Psaroudakis I, Dragoni G, Geldof J, Varkas G, Lambert J, Lobatón T

Open source

DOI: 10.1093/ecco-jcc/jjag129
Published: 2026 Sep 3
Container: Journal of Crohn's & colitis
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/ecco-jcc/jjag129,
  title = {Effect of JAK inhibitors on extraintestinal manifestations and concurrent immune-mediated inflammatory diseases in patients with inflammatory bowel disease.},
  author = {Truyens M and Tolstoy X and Calabrese G and Cremer A and Lewandowski K and Argyriou K and Drygiannakis I and Shakweh E and Pastras P and Kani HT and García MJ and Gordon H and Ribaldone DG and Karmiris K and Felice C and Yudego IM and Blesl A and Todeschini A and Balestrieri P and Filip R and Taelman T and Vladimirova N and Michalopoulos G and Attauabi M and Pouillon L and Noor N and Innocenti T and Vieujean S and Karakan T and Barreiro-de Acosta M and Mocci G and Estevinho MM and Savarino EV and Jauregui-Amezaga A and Holvoet T and Kapizioni C and Dagci G and Vrakas S and Hedin CRH and Nardone OM and Rydzewska G and Koutroubakis I and Psaroudakis I and Dragoni G and Geldof J and Varkas G and Lambert J and Lobatón T},
  year = {2026},
  journal = {Journal of Crohn's \& colitis},
  doi = {10.1093/ecco-jcc/jjag129},
  url = {https://doi.org/10.1093/ecco-jcc/jjag129}
}

RIS

TY  - JOUR
TI  - Effect of JAK inhibitors on extraintestinal manifestations and concurrent immune-mediated inflammatory diseases in patients with inflammatory bowel disease.
AU  - Truyens M
AU  - Tolstoy X
AU  - Calabrese G
AU  - Cremer A
AU  - Lewandowski K
AU  - Argyriou K
AU  - Drygiannakis I
AU  - Shakweh E
AU  - Pastras P
AU  - Kani HT
AU  - García MJ
AU  - Gordon H
AU  - Ribaldone DG
AU  - Karmiris K
AU  - Felice C
AU  - Yudego IM
AU  - Blesl A
AU  - Todeschini A
AU  - Balestrieri P
AU  - Filip R
AU  - Taelman T
AU  - Vladimirova N
AU  - Michalopoulos G
AU  - Attauabi M
AU  - Pouillon L
AU  - Noor N
AU  - Innocenti T
AU  - Vieujean S
AU  - Karakan T
AU  - Barreiro-de Acosta M
AU  - Mocci G
AU  - Estevinho MM
AU  - Savarino EV
AU  - Jauregui-Amezaga A
AU  - Holvoet T
AU  - Kapizioni C
AU  - Dagci G
AU  - Vrakas S
AU  - Hedin CRH
AU  - Nardone OM
AU  - Rydzewska G
AU  - Koutroubakis I
AU  - Psaroudakis I
AU  - Dragoni G
AU  - Geldof J
AU  - Varkas G
AU  - Lambert J
AU  - Lobatón T
PY  - 2026
JO  - Journal of Crohn's & colitis
DO  - 10.1093/ecco-jcc/jjag129
UR  - https://doi.org/10.1093/ecco-jcc/jjag129
ER  -

APA

M, T., X, T., G, C., A, C., K, L., K, A., I, D., E, S., P, P., HT, K., MJ, G., H, G., DG, R., K, K., C, F., IM, Y., A, B., A, T., P, B., R, F., T, T., N, V., G, M., M, A., L, P., N, N., T, I., S, V., T, K., M, B. A., G, M., MM, E., EV, S., A, J., T, H., C, K., G, D., S, V., CRH, H., OM, N., G, R., I, K., I, P., G, D., J, G., G, V., J, L., & T, L. (2026). Effect of JAK inhibitors on extraintestinal manifestations and concurrent immune-mediated inflammatory diseases in patients with inflammatory bowel disease.. Journal of Crohn's & colitis. https://doi.org/10.1093/ecco-jcc/jjag129

Source records

pubmed · retrieved 2026-09-26T03:24:28.471Z